Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herombopag for T-DM1-Induced Thrombocytopenia in Breast Cancer
NCT07257809Phase 2Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Oct 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hetrombopag in Thrombocytopenia, sponsored by Sun Yat-sen Memorial Hospital. Started Oct 2025; status: recruiting.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07257809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257809.